Curetis
Holzgerlingen
About Curetis
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $98.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2019)
- Ticker: ams:CURE
- Website: curetis.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/curetis-2212581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.